Bioventus Inc. (BVS)

NASDAQ: BVS · Real-Time Price · USD

13.07

+0.38 (2.96%)

At close: Oct 9, 2026, 4:00 PM EDT

13.12

+0.05 (0.42%)

After-hours: Oct 9, 2026, 7:30 PM EDT

Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,099	498	686	332	162	861
Market Cap Growth	142.96%	-27.40%	106.84%	105.22%	-81.23%	-
Enterprise Value	1,332	838	1,086	775	605	1,054
Last Close Price	13.06	7.44	10.50	5.27	2.61	14.49

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.70	21.92	-	-	-	-
Forward PE	16.38	9.79	20.00	21.82	17.17	21.50
PS Ratio	1.89	0.88	1.20	0.65	0.32	2.00
PB Ratio	3.90	2.18	3.70	1.50	0.39	1.61
P/FCF Ratio	11.65	6.91	18.16	41.57	-	90.94
P/OCF Ratio	11.34	6.67	17.69	21.63	-	37.46
PEG Ratio	1.49	0.82	0.82	0.82	0.82	2.07

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.29	1.48	1.90	1.51	1.18	2.45
EV/EBITDA Ratio	16.62	10.80	19.48	26.88	-	25.38
EV/EBIT Ratio	21.98	14.88	29.66	382.69	-	50.07
EV/FCF Ratio	14.13	11.63	28.75	97.14	-	111.28

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.95	1.36	1.92	1.90	1.06	0.71
Debt / EBITDA Ratio	3.08	3.74	5.79	11.81	719.64	8.23
Debt / FCF Ratio	2.80	4.32	9.42	52.70	-	39.72
Net Debt / Equity Ratio	0.84	1.14	1.69	1.74	0.99	0.62
Net Debt / EBITDA Ratio	2.91	3.35	5.64	13.30	-86.70	8.00
Net Debt / FCF Ratio	2.48	3.61	8.32	48.07	-16.20	35.09
Asset Turnover	0.84	0.81	0.75	0.47	0.39	0.50
Inventory Turnover	2.07	2.06	2.01	2.09	2.47	2.82
Quick Ratio	1.11	1.12	0.80	0.91	0.55	0.93
Current Ratio	1.69	1.70	1.31	1.53	0.90	1.46
Return on Equity (ROE)	25.68%	13.17%	-23.14%	-38.27%	-30.58%	3.38%
Return on Assets (ROA)	5.49%	4.99%	2.97%	0.12%	-1.67%	1.53%
Return on Invested Capital (ROIC)	12.15%	11.40%	6.63%	0.29%	-4.12%	3.73%
Return on Capital Employed (ROCE)	11.60%	10.80%	7.10%	0.30%	-3.20%	2.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.96%	4.56%	-5.26%	-47.08%	-98.15%	2.25%
FCF Yield	8.58%	14.47%	5.51%	2.40%	-15.50%	1.10%
Buyback Yield / Dilution	-5.97%	-6.77%	-3.03%	-2.05%	-35.00%	-828.01%

SEC Filings: 10-K · 10-Q